U.S. Physical Therapy (NYSE:USPH) Announces Earnings Results

U.S. Physical Therapy (NYSE:USPH) posted its quarterly earnings results on Tuesday. The company reported $0.51 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The company had revenue of $155.70 million during the quarter, compared to the consensus estimate of $153.30 million. During the same period in the previous year, the business earned $0.59 earnings per share. U.S. Physical Therapy’s revenue was up 4.8% on a year-over-year basis.

U.S. Physical Therapy Trading Up 0.4 %

Shares of USPH stock traded up $0.47 during trading hours on Friday, reaching $105.50. The company’s stock had a trading volume of 14,612 shares, compared to its average volume of 68,624. The stock has a market capitalization of $1.59 billion, a P/E ratio of 77.84, a P/E/G ratio of 4.99 and a beta of 1.39. The firm’s fifty day simple moving average is $105.32 and its 200 day simple moving average is $96.43. U.S. Physical Therapy has a one year low of $78.08 and a one year high of $124.11. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.29.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date of this dividend is Wednesday, May 22nd. U.S. Physical Therapy’s payout ratio is 130.37%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on USPH shares. JPMorgan Chase & Co. lifted their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a report on Wednesday, March 13th. Barrington Research reiterated an “outperform” rating and set a $122.00 price target on shares of U.S. Physical Therapy in a research report on Thursday. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $125.67.

Insider Buying and Selling

In other news, CFO Carey P. Hendrickson sold 1,800 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Richard Binstein sold 2,000 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $106.55, for a total transaction of $213,100.00. Following the sale, the executive vice president now directly owns 15,006 shares of the company’s stock, valued at approximately $1,598,889.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Carey P. Hendrickson sold 1,800 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the transaction, the chief financial officer now owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The disclosure for this sale can be found here. Insiders sold a total of 10,829 shares of company stock valued at $1,141,535 over the last three months. Corporate insiders own 1.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.